Haemonetics Corporation (HAE)

Debt-to-assets ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Long-term debt	US$ in thousands	797,564	856,849	748,662	751,381	754,102	756,826	759,552	763,141	559,441	633,118	698,043	767,345	690,592	292,721	297,016	296,893	305,513	309,738	313,984	318,144
Total assets	US$ in thousands	2,195,590	2,200,430	2,011,280	1,962,260	1,934,820	1,878,070	1,865,110	1,820,530	1,859,730	1,831,380	1,801,500	1,794,190	1,819,920	1,318,070	1,418,170	1,433,170	1,267,110	1,237,750	1,190,540	1,259,610
Debt-to-assets ratio		0.36	0.39	0.37	0.38	0.39	0.40	0.41	0.42	0.30	0.35	0.39	0.43	0.38	0.22	0.21	0.21	0.24	0.25	0.26	0.25

March 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $797,564K ÷ $2,195,590K
= 0.36

The debt-to-assets ratio of Haemonetics Corporation has shown some fluctuation over the past several quarters. As of March 31, 2024, the ratio stands at 0.36, indicating that the company finances approximately 36% of its assets through debt.

Looking at the trend over the past two years, the ratio has generally been in the range of 0.30 to 0.42, with some variability. It peaked at 0.43 in the second quarter of 2021 and hit a low of 0.21 in the third and fourth quarters of 2020.

A decreasing trend in the debt-to-assets ratio can signify a more conservative approach to leverage and a stronger financial position, while an increasing trend may indicate higher levels of debt relative to assets. It is important to assess this ratio in conjunction with other financial metrics to get a comprehensive view of Haemonetics Corporation's overall financial health.